Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  BTG    BTG   GB0001001592

BTG (BTG)
My previous session
Most popular
  Report  
Real-time Quote. Real-time Cboe Europe - 12/17 09:47:05 am
828 GBp   +0.06%
09/27BTG PLC : half-yearly sales release
03/29BTG PLC : annual sales release
2017U.S. tax cuts mix pleasure and pain for Europe's dollar earners
RE
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations

BTG : Form 8.3 - BTG plc

share with twitter share with LinkedIn share with facebook
share via e-mail
0
12/07/2018 | 12:37pm CET

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the 'Code')

1. KEY INFORMATION

(a) Full name of discloser:

Standard Life Aberdeen plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

BTG plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

6 December 2018

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state 'N/A'

No

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:

10p ordinary

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

20,115,964

5.20

(2) Cash-settled derivatives:

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

TOTAL:

20,115,964

5.20

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors' and other employee options)

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security

Purchase/sale

Number of securities

Price per unit

10p ordinary

Sale

759

GBP 8.265

10p ordinary

Sale

66,500

GBP 8.345

(b) Cash-settled derivative transactions

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

(ii) Exercise

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state 'none'

None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state 'none'

None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?

No

Date of disclosure:

7 December 2018

Contact name:

David McVeigh

Telephone number:

+44 (0)1224 404276

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

Disclaimer

BTG plc published this content on 07 December 2018 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 07 December 2018 11:36:03 UTC

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on BTG
12/14MAGNETAR CAPITAL PARTNERS LP : - Form 8.3 - BTG PLC
PR
12/14BTG : Form 8.5 (EPT/RI)- BTG plc AMENDMENT
PU
12/14FORM 8.3 - THE VANGUARD GROUP, INC. : BTG plc
PU
12/14BTG : Form 8.3 - BTG Group
PU
12/14BTG : Form 8.3 -
PU
12/14BTG : Form 8.5 (EPT/NON-RI) - BTG PLC
PU
12/14BTG : Form 8.5 (EPT/RI)- BTG plc
PU
12/14BTG : Form 8.5 (EPT/RI) BTG Plc - Amendment
PU
12/14BTG : Form 8.3 - BTG plc
PU
12/13BTG : Form 8.3 - BTG PLC - updated form
PU
More news
Financials (GBP)
Sales 2019 678 M
EBIT 2019 176 M
Net income 2019 98,2 M
Finance 2019 384 M
Yield 2019 0,03%
P/E ratio 2019 41,68
P/E ratio 2020 35,62
EV / Sales 2019 4,16x
EV / Sales 2020 4,12x
Capitalization 3 204 M
Chart BTG
Duration : Period :
BTG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BTG
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 9
Average target price 7,63  GBP
Spread / Average Target -7,8%
EPS Revisions
Managers
NameTitle
Pamela Louise Dame Makin Chief Executive Officer & Executive Director
Garry Watts Chairman
Duncan Kennedy Chief Financial Officer & Director
Melanie Georgina Lee Chief Scientific Officer
William James O'Shea Independent Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
BTG8.52%4 055
JOHNSON & JOHNSON-4.81%356 703
PFIZER20.93%254 040
NOVARTIS5.61%223 295
ROCHE HOLDING LTD.1.38%216 307
MERCK AND COMPANY35.92%198 877